EUVIMEDEUVIMED entdecken
Open Access

RP11-439C15.4 inhibits the malignant progression of hepatocellular carcinoma via binding to DHX9 and facilitating its degradation

Xuejiao Li, Zhongying Hu, Yina Sun, Tingting Wang, Xijing Yan, Qiang You, Kunhua Hu, Jia Yao, Xiaofeng Yuan, Rong Li

Acta Biochimica et Biophysica Sinica · 2026

DOI: 10.3724/abbs.2025122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2026. Verfasst von Xuejiao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, DEAD-box RNA Helicases, RNA, Long Noncoding. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDEAD-box RNA HelicasesRNA, Long NoncodingHumansAnimalsCell ProliferationDisease ProgressionMiceCell MovementCell Line, TumorGene Expression Regulation, NeoplasticMice, NudeMaleProteolysisFemaleMice, Inbred BALB CUbiquitinationSorafenibNeoplasm Proteins

Stichwörter der Autor:innen

DHX9RP11-439C15.4hepatocellular carcinomamalignant progression

Substanzen

DEAD-box RNA HelicasesRNA, Long NoncodingDHX9 protein, humanSorafenibNeoplasm Proteins

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
  • Department of Laboratory Medicine, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
  • Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-sen University; Organ Transplantation Research Center of Guangdong Province, Guangdong Province Engineering Labo…
  • Department of Breast and Thyroid Surgery, Lingnan Hospital, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510530, China.
  • Department of General Intensive Care Unit, Lingnan Hospital, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510530, China.

Zitieren

APA

Li, X., Hu, Z., Sun, Y., Wang, T., Yan, X., You, Q., Hu, K., Yao, J., Yuan, X., & Li, R. (2026). RP11-439C15.4 inhibits the malignant progression of hepatocellular carcinoma via binding to DHX9 and facilitating its degradation. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025122

Vancouver

Li X, Hu Z, Sun Y, Wang T, Yan X, You Q, et al. RP11-439C15.4 inhibits the malignant progression of hepatocellular carcinoma via binding to DHX9 and facilitating its degradation. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2025122

BibTeX
@article{Li2026,
  author = {Li, Xuejiao and Hu, Zhongying and Sun, Yina and Wang, Tingting and Yan, Xijing and You, Qiang and Hu, Kunhua and Yao, Jia and Yuan, Xiaofeng and Li, Rong},
  title = {RP11-439C15.4 inhibits the malignant progression of hepatocellular carcinoma via binding to DHX9 and facilitating its degradation},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2026},
  doi = {10.3724/abbs.2025122}
}
Kostenlos starten →